deltatrials
Completed NA INTERVENTIONAL 2-arm NCT02062593

Objective Randomised Blinded Investigation With Optimal Medical Therapy of Angioplasty in Stable Angina (ORBITA)

Defining a Gold Standard for Ischaemia: Effects of Interventional Revascularisation Versus Optimum Medical Therapy on Exercise Capacity in Patients With Stable Coronary Artery Disease

Sponsor: Imperial College London

Conditions Stable Angina
Updated 12 times since 2017 Last updated: Jan 18, 2024 Started: Dec 31, 2013 Primary completion: Aug 31, 2017 Completion: Sep 30, 2017
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Stable Angina and is currently completed. Imperial College London leads this study, which shows 12 recorded versions since 2013 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotRecruiting~Feb 2017 – ~Oct 2017 · 8 months · monthly snapshotRecruiting~Oct 2017 – ~Jun 2018 · 8 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotCompleted~Jan 2021 – ~May 2021 · 4 months · monthly snapshotCompleted~May 2021 – ~Dec 2022 · 19 months · monthly snapshotCompleted~Dec 2022 – ~Jan 2023 · 31 days · monthly snapshotCompleted~Jan 2023 – ~Feb 2024 · 13 months · monthly snapshotCompleted~Feb 2024 – ~Jul 2024 · 5 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotCompleted~Sep 2025 – present · 11 months · monthly snapshotCompleted

Change History

12 versions recorded
  1. Sep 2025 — Present [monthly]

    Completed NA

  2. Sep 2024 — Sep 2025 [monthly]

    Completed NA

  3. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  4. Feb 2024 — Jul 2024 [monthly]

    Completed NA

  5. Jan 2023 — Feb 2024 [monthly]

    Completed NA

Show 7 earlier versions
  1. Dec 2022 — Jan 2023 [monthly]

    Completed NA

  2. May 2021 — Dec 2022 [monthly]

    Completed NA

  3. Jan 2021 — May 2021 [monthly]

    Completed NA

  4. Jun 2018 — Jan 2021 [monthly]

    Completed NA

  5. Oct 2017 — Jun 2018 [monthly]

    Completed NA

    Status: RecruitingCompleted

  6. Feb 2017 — Oct 2017 [monthly]

    Recruiting NA

  7. Jan 2017 — Feb 2017 [monthly]

    Recruiting NA

    First recorded

Dec 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Imperial College London
  • Volcano Corporation
Data source: Imperial College London

For direct contact, visit the study record on ClinicalTrials.gov .